Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ru Feng

Showing results (491-500 of 540) with videos related to

Pageof 54
Sort By:
Environmental Research|November 19, 2021
Improved morbidity-based air quality health index development using Bayesian multi-pollutant weighted modelWen-Zhong Huang, Wei-Yun He, Luke D Knibbs, et al.
BMJ Open|December 30, 2023
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort studyLinjing Cai, Huan Chen, Yongqiang Wei, et al.
Oncotarget|July 25, 2016
Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patientsXin Wang, Jing Jin, Yong Yang, et al.
Journal of Hematology & Oncology|October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trialsKeshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Nature Communications|March 30, 2021
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemiaGanqian Zhu, Huacheng Luo, Yang Feng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
Cancer Medicine|September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysisYuqin Song, Keshu Zhou, Dehui Zou, et al.
Advances in Therapy|July 28, 2022
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three StudiesWei Xu, Shenmiao Yang, Constantine S Tam, et al.
Platelets|November 15, 2014
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational studyXiao Hui Zhang, Ru Feng, Lan Ping Xu, et al.
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
Pageof 54

Showing results (491-500 of 540) with videos related to

Sort By:
Pageof 54
Environmental Research|November 19, 2021
Improved morbidity-based air quality health index development using Bayesian multi-pollutant weighted modelWen-Zhong Huang, Wei-Yun He, Luke D Knibbs, et al.
BMJ Open|December 30, 2023
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort studyLinjing Cai, Huan Chen, Yongqiang Wei, et al.
Oncotarget|July 25, 2016
Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patientsXin Wang, Jing Jin, Yong Yang, et al.
Journal of Hematology & Oncology|October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trialsKeshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Nature Communications|March 30, 2021
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemiaGanqian Zhu, Huacheng Luo, Yang Feng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
Cancer Medicine|September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysisYuqin Song, Keshu Zhou, Dehui Zou, et al.
Advances in Therapy|July 28, 2022
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three StudiesWei Xu, Shenmiao Yang, Constantine S Tam, et al.
Platelets|November 15, 2014
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational studyXiao Hui Zhang, Ru Feng, Lan Ping Xu, et al.
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
Pageof 54